The Need for Axillary Dissection in Patients with Positive Axillary Sentinel Lymph Nodes Randal L. CroshawKathleen M. ErbThomas B. Julian ReviewPaper 19 October 2010 Pages: 5 - 10
The Place for Eribulin in the Treatment of Metastatic Breast Cancer William J. Gradishar ReviewPaper 23 November 2010 Pages: 11 - 16
The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury? Mustafa KhasrawEdi BrogiAndrew D. Seidman ReviewPaper 30 October 2010 Pages: 17 - 25
Tumor Profiling: Development of Prognostic and Predictive Factors to Guide Brain Tumor Treatment Stephen H. SettleErik P. Sulman ReviewPaper 18 November 2010 Pages: 26 - 36
Patient Profiling for Treatment Toxicity: Potential Use of Clinical and Genomic Factors Terri S. ArmstrongMark R. Gilbert ReviewPaper 16 November 2010 Pages: 37 - 41
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments Evanthia GalanisWenting WuDavid A. Reardon ReviewPaper 03 December 2010 Pages: 42 - 49
Response Assessment in Neuro-Oncology Eudocia C. QuantPatrick Y. Wen ReviewPaper 19 November 2010 Pages: 50 - 56
Breast Cancer Screening with Mammography Bradford R. HirschGary H. Lyman ReviewPaper 26 November 2010 Pages: 63 - 70
Obesity and Cancer Risk: Recent Review and Evidence Karen Basen-EngquistMaria Chang ReviewPaper 16 November 2010 Pages: 71 - 76
Chemoradiotherapy for Cervical Cancer in 2010 Ann H. KloppPatricia J. Eifel ReviewPaper 02 November 2010 Pages: 77 - 85